Cargando…

Galectin-3 Knockdown Impairs Survival, Migration, and Immunomodulatory Actions of Mesenchymal Stromal Cells in a Mouse Model of Chagas Disease Cardiomyopathy

Therapies based on transplantation of mesenchymal stromal cells (MSC) hold promise for the management of inflammatory disorders. In chronic Chagas disease cardiomyopathy (CCC), caused by chronic infection with Trypanosoma cruzi, the exacerbated immune response plays a critical pathophysiological rol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Souza, Bruno Solano de Freitas, da Silva, Kátia Nunes, Silva, Daniela Nascimento, Rocha, Vinícius Pinto Costa, Paredes, Bruno Diaz, Azevedo, Carine Machado, Nonaka, Carolina Kymie, Carvalho, Gisele Batista, Vasconcelos, Juliana Fraga, dos Santos, Ricardo Ribeiro, Soares, Milena Botelho Pereira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523546/ https://www.ncbi.nlm.nih.gov/pubmed/28769980 http://dx.doi.org/10.1155/2017/3282656

Ejemplares similares

Intramyocardial transplantation of cardiac mesenchymal stem cells reduces myocarditis in a model of chronic Chagas disease cardiomyopathy
por: Silva, Daniela Nascimento, et al.
Publicado: (2014)

Granulocyte-Colony Stimulating Factor-Overexpressing Mesenchymal Stem Cells Exhibit Enhanced Immunomodulatory Actions Through the Recruitment of Suppressor Cells in Experimental Chagas Disease Cardiomyopathy
por: Silva, Daniela N., et al.
Publicado: (2018)

Therapeutic effects of sphingosine kinase inhibitor N,N-dimethylsphingosine (DMS) in experimental chronic Chagas disease cardiomyopathy
por: Vasconcelos, Juliana Fraga, et al.
Publicado: (2017)

IGF-1-Overexpressing Mesenchymal Stem/Stromal Cells Promote Immunomodulatory and Proregenerative Effects in Chronic Experimental Chagas Disease
por: Silva, Daniela N., et al.
Publicado: (2018)

Assessment of Galectin-3 Polymorphism in Subjects with Chronic Chagas Disease
por: Cruz, Gabriela da Silva, et al.
Publicado: (2015)

Therapeutic miR-21 Silencing Reduces Cardiac Fibrosis and Modulates Inflammatory Response in Chronic Chagas Disease
por: Nonaka, Carolina Kymie Vasques, et al.
Publicado: (2021)

Tolerogenic Dendritic Cells Reduce Cardiac Inflammation and Fibrosis in Chronic Chagas Disease
por: Santos, Emanuelle de Souza, et al.
Publicado: (2020)

Circulating miRNAs as Potential Biomarkers Associated with Cardiac Remodeling and Fibrosis in Chagas Disease Cardiomyopathy
por: Nonaka, Carolina Kymie Vasques, et al.
Publicado: (2019)

Betulinic Acid Derivative BA5, Attenuates Inflammation and Fibrosis in Experimental Chronic Chagas Disease Cardiomyopathy by Inducing IL-10 and M2 Polarization
por: Meira, Cássio Santana, et al.
Publicado: (2019)

Exercise Training-Induced Changes in MicroRNAs: Beneficial Regulatory Effects in Hypertension, Type 2 Diabetes, and Obesity
por: Improta Caria, Alex Cleber, et al.
Publicado: (2018)

Lack of association between serum syndecan-4, myocardial fibrosis and ventricular dysfunction in subjects with chronic Chagas disease
por: Larocca, Ticiana Ferreira, et al.
Publicado: (2017)

Immunomodulatory and Anti-fibrotic Effects Following the Infusion of Umbilical Cord Mesenchymal Stromal Cells in a Critically Ill Patient With COVID-19 Presenting Lung Fibrosis: A Case Report
por: da Silva, Kátia Nunes, et al.
Publicado: (2021)

Galectin-3 and fibrosis intensity in Chronic Chagas Cardiomyopathy: a systematic review
por: Chaves, Ana Thereza, et al.
Publicado: (2022)

Immunomodulation for the Treatment of Chronic Chagas Disease Cardiomyopathy: A New Approach to an Old Enemy
por: Santos, Emanuelle de Souza, et al.
Publicado: (2021)

Cardiac Chagas Disease: MMPs, TIMPs, Galectins, and TGF-β as Tissue Remodelling Players
por: da Costa, Arthur Wilson Florencio, et al.
Publicado: (2019)

Advances in Hepatic Tissue Bioengineering with Decellularized Liver Bioscaffold
por: Rossi, Erik Aranha, et al.
Publicado: (2019)

A Novel High-Content Screening-Based Method for Anti-Trypanosoma cruzi Drug Discovery Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Portella, Diogo Crispim Nascimento, et al.
Publicado: (2021)

IGF-1 overexpression improves mesenchymal stem cell survival and promotes neurological recovery after spinal cord injury
por: Allahdadi, Kyan James, et al.
Publicado: (2019)

Immunomodulatory effects of galectin-1 in patients with chronic lymphocytic leukemia
por: Kostic, Milos, et al.
Publicado: (2021)

Immune exhaustion in chronic Chagas disease: Pro-inflammatory and immunomodulatory action of IL-27 in vitro
por: Natale, María Ailén, et al.
Publicado: (2021)

Rapid Detection of SARS-CoV-2 Based on the LAMP Assay Associated with the CRISPRCas12a System
por: de Sousa, Karoline Almeida Felix, et al.
Publicado: (2023)

Bone marrow-derived mesenchymal stem/stromal cells reverse the sensorial diabetic neuropathy via modulation of spinal neuroinflammatory cascades
por: Evangelista, Afrânio Ferreira, et al.
Publicado: (2018)

Assessment of speckle tracking strain predictive value for myocardial fibrosis in subjects with Chagas disease
por: Macedo, Carolina Thé, et al.
Publicado: (2015)

Arylimidamides Have Potential for Chemoprophylaxis against Blood-Transmitted Chagas Disease
por: Timm, Bruno Lisboa, et al.
Publicado: (2023)

Administration of granulocyte-colony stimulating factor accompanied with a balanced diet improves cardiac function alterations induced by high fat diet in mice
por: Daltro, Pâmela Santana, et al.
Publicado: (2015)

Electrophysiological characteristics of Chagas disease
por: Cedraz, Swellen Schuenemann, et al.
Publicado: (2013)

Modulation of MicroRNAs as a Potential Molecular Mechanism Involved in the Beneficial Actions of Physical Exercise in Alzheimer Disease
por: Improta-Caria, Alex Cleber, et al.
Publicado: (2020)

Galectins in Chagas Disease: A Missing Link Between Trypanosoma cruzi Infection, Inflammation, and Tissue Damage
por: Poncini, Carolina V., et al.
Publicado: (2022)

Hepatic changes by benznidazole in a specific treatment for Chagas disease
por: Pavan, Tycha Bianca Sabaini, et al.
Publicado: (2018)

Asteraceae Plants as Sources of Compounds Against Leishmaniasis and Chagas Disease
por: Moraes Neto, Roberval Nascimento, et al.
Publicado: (2019)

CD86 Expression by Monocytes Influences an Immunomodulatory Profile in Asymptomatic Patients with Chronic Chagas Disease
por: Pinto, Bruna F., et al.
Publicado: (2018)

How Can Galectin-3 as a Biomarker of Fibrosis Improve Atrial Fibrillation Diagnosis and Prognosis?
por: da Silveira, Maria Mariana Barros Melo, et al.
Publicado: (2020)

Insights from the use of erythropoietin in experimental Chagas disease
por: de Castro Nobre, Ana Carolina, et al.
Publicado: (2022)

Chronotropic incompetence in Chagas disease: effectiveness of blended sensor (volume/minute and accelerometer)
por: Menezes Junior, Antonio da Silva, et al.
Publicado: (2015)

Is there a place for mesenchymal stromal cell-based therapies in the therapeutic armamentarium against COVID-19?
por: da Silva, Kátia Nunes, et al.
Publicado: (2021)

Evaluation of urine SARS-COV-2 RT-PCR as a predictor of acute kidney injury and disease severity in patients with critical COVID-19
por: de Souza, Sérgio Pinto, et al.
Publicado: (2021)

Immunomodulatory Effects of Cinnamaldehyde in Staphylococcus aureus-Infected Wounds
por: Figueiredo, Cristiane Santos Silva e Silva, et al.
Publicado: (2023)

The Presence and Extension of Myocardial Fibrosis in the Undetermined Form of Chagas’ Disease: A Study Using Magnetic Resonance
por: Noya-Rabelo, Marcia Maria, et al.
Publicado: (2018)

Molecular Hybridization Strategy on the Design, Synthesis, and Structural Characterization of Ferrocene-N-acyl Hydrazones as Immunomodulatory Agents
por: Silva, Laís Peres, et al.
Publicado: (2022)

Cytogenomic Investigation of Syndromic Brazilian Patients with Differences of Sexual Development
por: Faria, José Antonio Diniz, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s9mlfj12li4guuthoqfd92itg6